# ZIEXTENZO

NDC: 61314-866
Generic name: pegfilgrastim-bmez
Labeler / Manufacturer: Sandoz Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20191104

FDA application: BLA761045

## Active ingredients

- PEGFILGRASTIM: 6 mg/.6mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61314-866"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61314-866
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7dada041-6528-4acf-809c-62d271538c9a